Volume 11, 2024
|
|
Reviews
My battle with cancer. Part 1
https://doi.org/10.18632/oncoscience.593
Mikhail V. Blagosklonny
p 1-14
Abstract | PDF | Full Text | How to Cite | Press Release
Research Perspectives
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
https://doi.org/10.18632/oncoscience.594
Richard E. Kast
p 15-31
Abstract | PDF | Full Text | How to Cite | Press Release
Editorials
A very long and winding road: developing novel therapeutics for metastatic tumors
https://doi.org/10.18632/oncoscience.595
Paul Dent
p 32-33
PDF | Full Text | How to Cite | Press Release
Editorials
Exploring oncogenic driver molecular alterations in hispanic/latin american cancer patients: A call for enhanced molecular understanding
https://doi.org/10.18632/oncoscience.597
Rafael Parra-Medina
p 34-35
PDF | Full Text | How to Cite
Editorials
Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy
https://doi.org/10.18632/oncoscience.596
Ioannis A. Voutsadakis
p 36-37
PDF | Full Text | How to Cite
Editorials
The price of hope: CAR-T therapy in pediatric leukemia
https://doi.org/10.18632/oncoscience.598
Alex Hoover
p 38-39
PDF | Full Text | How to Cite
Editorials
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs
https://doi.org/10.18632/oncoscience.599
Jeetendra Kumar Nag, Amnon Hoffman, Chaim Gilon, Beatrice Uziely, Rachel Bar-Shavit
p 40-42
PDF | Full Text | How to Cite